,,iii #aaith ,,congress #b;d ,session ,s4 ,,res4 #geb ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,may #ba1 #bjbf,mr4 ,blumenthal submitted the following resolution2 which was referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,,resolution ,expressing support for the designation of the month of ,may #bjbf as ,progressive ,supranuclear ,palsy and ,corticobasal ,degeneration ,awareness ,month4 ,whereas progressive supranuclear palsy1 often referred to as ,,psp1 and corticobasal degeneration1 often referred to as ,,cbd1 are rare1 adult onset1 rapidly progressing neurodegenerative disorders that affect multiple areas of the brain and cause complex symptoms and care needs2 ,whereas1 although some symptoms may appear similar to those of other neurological diagnoses like ,parkinson's disease and frontotemporal dementia1 progressive supranuclear palsy and corticobasal degeneration are distinct diseases with their own unique trajectories and care needs2 ,whereas1 while estimates vary and the conditions are frequently misdiagnosed1 approximately #cj1jjj ,americans are living with progressive supranuclear palsy and #b1jjj ,americans are living with corticobasal degeneration2 ,whereas delays in the accurate diagnosis of progressive supranuclear palsy and corticobasal degeneration and access to neurology professionals specialized in these diseases are common and cause confusion1 anxiety1 and frustration among patients2 ,whereas progressive supranuclear palsy and corticobasal degeneration can cause significant difficulty with movement1 balance1 speech1 swallowing1 cognition1 vision1 mood1 and a variety of other complex symptoms2 ,whereas progressive supranuclear palsy and corticobasal degeneration are aggressive in their progression1 with most individuals becoming dependent on care in #c to #d years and having an overall life expectancy of #g to #h years from symptom onset2 ,whereas there are currently no disease-modifying treatments for progressive supranuclear palsy or corticobasal degeneration2 ,whereas more research is needed to understand the roles of environmental factors and genetics in why people develop progressive supranuclear palsy and corticobasal degeneration2 ,whereas there are countless family caregivers1 friends1 and loved ones whose lives are greatly affected by progressive supranuclear palsy and corticobasal degeneration2 ,whereas additional research1 support services1 and education are needed to maintain quality of life for those affected by the disease1 to develop better treatments and prevention of complications1 and to find cures for progressive supranuclear palsy and corticobasal degeneration2 and ,whereas the designation of the month of ,may #bjbf as ,progressive ,supranuclear ,palsy and ,corticobasal ,degeneration ,awareness ,month will benefit individuals diagnosed with the diseases1 families1 healthcare professionals1 and communities across the country and will further bolster awareness of the diseases3 ,now1 therefore1 be it ,that the ,senate-- 7#a7 supports the designation of ,may #bjbf as ,progressive ,supranuclear ,palsy and ,corticobasal ,degeneration ,awareness ,month2 7#b7 supports the goals and ideals of ,progressive ,supranuclear ,palsy and ,corticobasal ,degeneration ,awareness ,month2 7#c7 supports research on diagnosis1 prevention1 treatments1 and cures for progressive supranuclear palsy and corticobasal degeneration2 7#d7 recognizes the strength and resilience of the communities affected by progressive supranuclear palsy and corticobasal degeneration2 and 7#e7 commends the individuals1 families1 volunteers1 healthcare professionals1 researchers1 and organizations across the country who are working to improve the lives of people living with progressive supranuclear palsy and corticobasal degeneration4